New Delhi : The Delhi High Court has barred the export of generic kidney and liver cancer medication, Sorefenat, manufactured by Natco Pharma Ltd on the plea of German drug major Bayer Corporation.
Justice Manmohan, however, gave liberty to Natco to seek the court’s permission to export the drug as and when it gets the nod from the Drug Controlling Authority.
The court also issued notice to the Centre, customs authorities and Natco, seeking their replies on the plea of Bayer which has alleged that the generic drug is being made under compulsory licence for sale in India and thus, it cannot be exported.
Bayer has sought directions to the customs authorities to seize and confiscate the consignment.
'Mere Liye Sirf Ek Actress Thi': Co-Actor Inam-ul-Haq Of Radhika Yadav-Starrer Music Clip Breaks Silence On Shocking Death Of Gurugram Tennis Player; Video
Mercedes-Benz India Booms In FY 2025-26, Retailing 4,238 Units & Marking Best-Ever Q1 Result
Mumbai: Teacher Booked Under POCSO Act, BNS For Molesting 12-Year-Old Schoolgirl
Delhi University Begins Four-Year Undergraduate Program Under NEP 2020
